Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Customers Bancorp F Pref | CUBI-F | Jan 10, 2025 | 25.46 | -0.72 |
Cutera | CUTR | Jan 10, 2025 | 0.46 | +2.20 |
CVB Financial | CVBF | Jan 10, 2025 | 19.59 | -4.16 |
CVD Equipment | CVV | Jan 10, 2025 | 3.51 | -14.60 |
CVR Energy | CVI | Jan 10, 2025 | 18.95 | +1.94 |
Cvr Partners LP Unit | UAN | Jan 10, 2025 | 75.07 | +0.03 |
CVRx | CVRX | Jan 10, 2025 | 14.17 | 0.00 |
CVS Health | CVS | Jan 10, 2025 | 48.01 | +4.35 |
CXApp A | CXAI | Jan 10, 2025 | 1.83 | -6.39 |
CyberArk Software | CYBR | Jan 10, 2025 | 343.79 | -0.22 |
Cybin | CYBN | Jan 10, 2025 | 8.89 | -7.01 |
Cyclacel Pharmaceuticals | CYCC | Jan 10, 2025 | 0.42 | +1.21 |
Cyclacel Pharmaceuticals Pref | CYCCP | Jan 10, 2025 | 7.60 | -3.55 |
Cyclerion Therapeutics | CYCN | Jan 10, 2025 | 3.29 | +1.54 |
Cyclo Therapeutics | CYTH | Jan 10, 2025 | 0.62 | -9.71 |
Cyngn | CYN | Jan 10, 2025 | 0.55 | -8.38 |
Cytek Biosciences | CTKB | Jan 10, 2025 | 6.82 | -0.15 |
Cytokinetics | CYTK | Jan 10, 2025 | 46.62 | -1.58 |
Cytomed Therapeutics | GDTC | Jan 10, 2025 | 2.76 | +20.52 |
CytomX Therapeutics | CTMX | Jan 10, 2025 | 0.88 | -10.45 |
Cytosorbents | CTSO | Jan 10, 2025 | 0.94 | -3.33 |
D-MARKET Electronic Services & Trading ADR | HEPS | Jan 10, 2025 | 3.07 | -2.23 |
D-Wave Quantum | QBTS | Jan 10, 2025 | 5.77 | -5.41 |
D.R. Horton | DHI | Jan 10, 2025 | 136.52 | -2.42 |
Dada Nexus ADR | DADA | Jan 10, 2025 | 1.24 | -3.88 |
Daily Journal | DJCO | Jan 10, 2025 | 518.61 | -6.95 |
Dakota Gold | DC | Jan 10, 2025 | 2.27 | -1.30 |
Daktronics | DAKT | Jan 10, 2025 | 16.09 | -1.95 |
DallasNews A | DALN | Jan 10, 2025 | 7.10 | -0.70 |
Damon | DMN | Jan 10, 2025 | 0.77 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.